Press Releases

OAKLAND, Calif., Nov. 4, 2019 /PRNewswire/ -- After 80 years of doing business from its headquarters in San Francisco, Blue Shield of California has moved to the East Bay. The taxpaying, nonprofit health plan is putting down roots in the city of Oakland, leasing eight

VANCOUVER, Wash., Nov. 4, 2019 /PRNewswire/ -- Wisdom Health - the world's leader in pet genetics and researchers at Purdue University today announced the most compreh

INCHEON, South Korea, Nov. 4, 2019 /PRNewswire/ -- Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treatment for moderate-to-severe atopic dermatitis.

NEW HAVEN, Conn., Nov. 4, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) a clinical-stage biopharmaceutical company provided an update regarding the appointment of Thomas J. Lynch, Jr., MD, as Chairman of the Board at Kleo Pharmaceuticals. Biohaven's current ownership interest in outstanding stock of Kle

TOKYO and MUNICH and BASKING RIDGE, N.J., Nov. 4, 2019 /PRNewswire/ -- Daiichi Sankyo Co., Ltd announced today that the company has filed a Declaratory Judgement action in the District Court of Delaware in response to receiving communications from Seattle Genetics, Inc

HOUSTON, Nov. 4, 2019 /PRNewswire/ -- Cuddly bears named after Miguel and Bella, children who are being treated at St. Jude, are waiting at your local Stage and

-Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products -EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tenn., Nov. 4, 2019 /PRNewswire/ -- Cognate BioServices (Cognate), a leading contract development and manufacturi

PARIS, Nov. 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone® High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two inf

DENVER, Nov. 4, 2019 /PRNewswire/ -- Most adults are unprepared or lack confidence to help if a medical emergency occurs, according to a new public poll from the American College of Emergency Physicians (ACEP). And, that confidence wanes as medical emergencies become more serious.

STAINES-UPON-THAMES, United Kingdom, Nov. 4, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced it ha